Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|February 18, 1998
Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantationM Woo, D Przepiorka, C Ippoliti, et al.
Annals of Hematology|April 1, 1994
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: risk factors for early regimen-related toxicityD Przepiorka, M Dimopoulos, T Smith, et al.
Revue Scientifique Et Technique (International Office of Epizootics)|April 29, 2006
The use of a web-based interactive geographical information system for the surveillance of bluetongue in ItalyA Conte, P Colangeli, C Ippoliti, et al.
Veterinaria Italiana|April 27, 2010
Towards the identification of potential infectious sites for bluetongue in Italy: a spatial analysis approach based on the distribution of Culicoides imicolaA Conte, C Ippoliti, P Calistri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignanciesC Ippoliti, R Champlin, N Bugazia, et al.
Transboundary and Emerging Diseases|March 5, 2014
A geographical information system-based multicriteria evaluation to map areas at risk for Rift Valley fever vector-borne transmission in ItalyA Tran, C Ippoliti, T Balenghien, et al.
Bone Marrow Transplantation|February 3, 2004
Low-dose alemtuzumab (Campath) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: decreased incidence of acute graft-versus-host-disease with unique pharmacokineticsI F Khouri, M Albitar, R M Saliba, et al.
Archives De L'Institut Pasteur De Tunis|September 26, 2015
ANALYSIS OF BIOTIC AND ABIOTIC FACTORS INFLUENCING THE OCCURRENCE OF WEST NILE VIRUS INFECTION IN TUNISIATh Ben Hassine, P Calistri, C Ippoliti, et al.
Bone Marrow Transplantation|January 1, 1993
Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantationC Ippoliti, D Przepiorka, S Giralt, et al.
Leukemia & Lymphoma|May 1, 1995
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphomaD Przepiorka, R Nath, C Ippoliti, et al.
Pageof 5